Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Open accessPublished version of a preprint
The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; 17 of the 28 sources its claims cite were checked for support.
Abstract
Abstract Ageing is the biggest risk factor for cardiovascular disease. Cellular senescence, a process driven in part by telomere shortening, has been implicated in age‐related tissue dysfunction. Here, we address the question of how senescence is induced in rarely dividing/post‐mitotic cardiomyocytes and investigate whether clearance of senescent cells attenuates age‐related cardiac dysfunction. During ageing, human and murine cardiomyocytes acquire a senescent‐like phenotype characterised by persistent DNA damage at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur independently of cell division and telomere length. Length‐independent telomere damage in cardiomyocytes activates the classical senescence‐inducing pathways, p21 CIP and p16 INK4a , and results in a non‐canonical senescence‐associated secretory phenotype, which is pro‐fibrotic and pro‐hypertrophic. Pharmacological or genetic clearance of senescent cells in mice alleviates detrimental features of cardiac ageing, including myocardial hypertrophy and fibrosis. Our data describe a mechanism by which senescence can occur and contribute to age‐related myocardial dysfunction and in the wider setting to ageing in post‐mitotic tissues.
Overview
CoChat Summary
## TL;DR
The paper argues that ageing cardiomyocytes acquire a senescent-like state through persistent telomere-associated DNA damage that is independent of telomere shortening, cell division, and telomerase activity. Clearing senescent cells in mice reduced cardiomyocyte hypertrophy and fibrosis, suggesting a therapeutic angle for age-related cardiac dysfunction.
## Key findings
- In mouse and human hearts, mean telomere-associated foci (TAF) per cardiomyocyte and the percentage of cardiomyocytes with TAF increased significantly with age, while total γH2A.X foci did not change with age.
- In purified cardiomyocytes from young (3 months) vs old (20 months) mice, RNA-seq found 416 differentially expressed genes; principal component analysis separated the groups with the first two components explaining 80.1% and 7.8% of variance.
- Aged cardiomyocytes upregulated senescence markers and hypertrophy-related genes: p16Ink4a, p21CIP, and p15Ink4b increased, and hypertrophy genes including Myh7 and Acta1 increased, but canonical SASP genes such as Il-1α, Il-1β, Il-6, Cxcl1, and Cxcl2 were not differentially expressed.
- Senescent-cell clearance improved cardiac structure: in aged INK-ATTAC mice, AP treatment reduced p16Ink4a- and eGFP-positive cells, reduced TAF in cardiomyocytes, reduced average cardiomyocyte cross-sectional area, and decreased fibrosis; navitoclax likewise significantly reduced hypertrophy and fibrosis in aged wild-type mice.
- Navitoclax increased evidence of cardiomyocyte renewal: EdU-labelled cardiomyocytes increased from 0.07% in vehicle controls to 0.23% with navitoclax.
## Methods
- The study combined in vivo ageing and intervention experiments in mice with human heart tissue from patients undergoing open-heart surgery for aortic stenosis, plus multiple cell culture systems (rat neonatal cardiomyocytes, mouse embryonic cardiomyocytes, H9C2 myoblasts, and AC10 cells).
- Telomere damage was assessed mainly by dual immuno-FISH for DDR proteins (γH2A.X, 53BP1) co-localised with telomeres, along with STED microscopy, ChIP-qPCR for γH2A.X at telomeres, SA-β-Gal staining, RNA-seq, and cytokine assays.
- Causality was tested using telomere-targeted damage (TRF1-FokI), oxidative stress/mitochondrial dysfunction models, and senescent-cell clearance via INK-ATTAC/AP20187 and the senolytic navitoclax (ABT263).
## Limitations
- The paper states that interphase telomere FISH does not identify telomeres on specific chromosomes or detect telomere-free ends; it also notes that with 3-μm tissue sections, the entirety of cardiomyocyte nuclei may not be captured.
- The authors note that although STED improved resolution, clusters of telomeres may still not be fully resolved.
- Evident from the text: several mechanistic links are correlative rather than definitively causal in vivo, and the authors explicitly say it remains possible that mitochondrial dysfunction is a consequence, rather than the cause, of telomere dysfunction.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
12 Valid · 0 Not valid · 8 Not checked · 110 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Work by us and others previously demonstrated demonstrated that stress exposure leads to activation of a persistent DDR at telomeric regions”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Telomere damage is persistent in cardiomyocytes
What the sources say
- Supportedcites Fumagalli et al, 2012 matched to “Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation” (2012) source
The Results section on DDR markers during physiological ageing states that exposure to exogenous or endogenous DNA damage can produce breaks at telomeres that remain unrepaired, resulting in persistent DDR foci. This supports the claim when stress exposure refers to DNA-damaging stress. (LLM, conf=0.93)
- Supportedcites Hewitt et al, 2012 matched to “Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence” (2012) source
The paper reports that DNA damage foci induced by exogenous stress are preferentially located at telomeres and that persistent foci are associated with telomeres (Abstract). The Results section, “TAF are persistent in stress-induced senescence,” also reports enrichment of the DDR marker γH2A.X at telomere repeats 10 days after irradiation. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Coppé et al, 2008 matched to “Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor” (2008) source
The citation supports the description of these as pro-inflammatory SASP-associated genes, not the citing authors’ finding about young and aged cardiomyocytes. The paper describes inflammatory cytokines and chemokines as SASP components, including IL-6, and identifies IL-1α and IL-1β as SASP factors; the cardiomyocyte comparison is not attributed to it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS)”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Swanson et al, 2013 matched to “Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence” (2013) source
The Results section (‘Marked distension of satellite DNA in a subset of primary human fibroblasts’; page unavailable) identifies distended centromeric satellite signals using DNA hybridization. The section on senescent murine cells likewise reports distended centromeric signals and calls this change SADS. The age-dependent cardiomyocyte finding is explicitly the citing authors’ own observation (‘we also observed’), not a finding attributed to this source. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In mouse models of accelerated telomere shortening, critically short telomeres have been shown to repress PGC1‐α‐ and β‐mediated mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Supportedcites Sahin et al, 2011 matched to “Telomere dysfunction induces metabolic and mitochondrial compromise” (2011) source
The section “Telomere dysfunction represses PGC network and mitochondrial biogenesis” describes successive generations of telomerase-deficient mice with decreasing telomere reserves and reports reduced PGC-1α and PGC-1β expression in mice with severe telomere dysfunction. The Discussion states that these analyses established a link between telomere dysfunction and repression of PGC-dependent mitochondrial biogenesis. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Supportedcites Chang et al, 2016 matched to “Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy” (2016) source
The Results (Fig. 3 legend, p. —) state 'Critically short telomeres lead to activation of p53, leading to decreased mitochondrial biogenesis' with reduced Pgc1α and Pgc1β transcripts, and the Results text concludes that 'critically shortened telomeres in dystrophin-deficient cardiomyocytes in conjunction with a DNA damage response block mitochondrial biogenesis.' The Discussion additionally describes the TERT G4 null mouse model of ubiquitous telomere shortening developing mitochondrial dysfunction 'because of p53-dependent inhibition of PGC1α/β,' and the Significance section summarizes reduced mitochondrial biogenesis via p53 activation in the humanized-telomere mdx4cv/mTR model. Thus the mouse-model attribution of short-telomere repression of PGC1α/β-mediated mitochondrial biogenesis is stated in our copy. (LLM, conf=0.90)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Partly supportedcites Baker et al, 2016 matched to “Naturally occurring p16Ink4a-positive cells shorten healthy lifespan” (2016) sourceExperimental — accuracy not yet measured
The section “p16Ink4a-positive cells contribute to cardiac aging” (page not provided) reports no significant difference in resting echocardiographic measures between treated and untreated 18-month-old mice, and preserved cardiac stress tolerance after treatment. But the paper describes clearance of p16Ink4a-positive cells, not specifically the loss of senescent cardiomyocytes; the identified senescence-marker-positive cardiac cells include pericardial epithelial cells and fibroblasts and aortic-root smooth muscle cells. (LLM, conf=0.88)
- Could not verifycites Roos et al, 2016 matched to “Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice” (2016) sourceExperimental — accuracy not yet measured
The age-related vascular pathology section reports clearance of senescent cells from the aortic vessel wall and improved carotid artery relaxation in aged mice. The copy does not report loss of senescent cardiomyocytes or assess whether their loss adversely affects cardiac function (searched: cardiomyocytes, cardiac function, heart function, echocardiography). (LLM, conf=0.74)
- Partly supportedcites Demaria et al, 2017 matched to “Cellular senescence promotes adverse effects of chemotherapy and cancer relapse” (2017) sourceExperimental — accuracy not yet measured
In Results (“Inflammation, bone marrow recovery and heart function”; page unavailable), eliminating senescent cells after doxorubicin treatment almost completely prevented declines in cardiac function. But the paper says those cardiac senescent cells were primarily endothelial cells and fibroblast-like cells, not cardiomyocytes. It therefore does not establish that loss of senescent cardiomyocytes is harmless in aged mice. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims
Create a free account to see all 130 claims and to verify the 4 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 46
- The quote only partly states this claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“genetic and pharmacological clearance of p16-expressing senescent cells ameliorated heart functions in aged mice140.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [140]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice, despite having long telomeres and ubiquitous telomerase expression, show an age-dependent increase in dysfunctional telomeres in both proliferating and non-proliferating tissues20,34–37.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the levels of DDR markers and TAFs increase during ageing in different mammalian tissues.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The clearance of senescent cells in aged mice improves heart functions and reduces the fraction of TAF-positive cardiomyocytes without a significant effect on mean telomere length36.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clearance of senescent cells in aged mice and in mice with atherosclerosis using genetic and pharmacological approaches improves vascular and myocardial function and attenuates age-dependent remodelling.25,27”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Hearts from mixed‐sex CJ57/BL6 mice were placed on a Langendorff setup.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Mixed‐sex C57BL/6 mice were analysed at either 3, 15, 20, 24 or 30 months of age.”
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Senescence-associated b -galactosidase activity assay SA-b -Gal activity assay was performed as described previously (Dimri et al , 1995).”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · cited 1×
“Telomere shortening has been proposed as a major inducer of senescence (Bodnar et al , 1998).”
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationHucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060 · cited 1×
“The models were encoded in the Systems Biology Markup Language (SBML) modelling standard (Hucka et al , 2003) with the Python SBML shorthand tool (Wilkinson, 2011).”
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“…associated with a protein complex known as shelterin (de Lange, 2005), which facilitates the formation of a lariat-like structure to shield the exposed end of DNA (Griffith et al , 1999), thus protecting the ends of chromosomes from being recognised as DNA damage (d’Adda di Fagagna et al , 2003).”
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 3×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“Furthermore, we found a significant increase in TAF in CMs from Polg mut/mut mice, a model of accelerated ageing due to mitochondrial dysfunction (Trifunovic et al , 2004; Fig 6G).”
Cited by
Items 201–300 of 523
Loss of DNA repair mechanisms in cardiac myocytes induce dilated cardiomyopathy
Henpita, C., Vyas, R., Healy, C. L., Kieu, T. L., Gurkar, A. U., Yousefzadeh, M. J., Cui, Y., Lu, A., Angelini, L. A., O'Kelly, R. D., et al. (2023) · Aging Cell · doi:10.1111/acel.13782 · Cited by 31
“There is convincing data supporting detection of senescence in cardiomyocytes isolated from adult mouse heart (Anderson et al., 2019).”
BackgroundTelomere length and associated factors in older adults with hypertension
Liu, P., Zhang, Y., & Ma, L. (2019) · Journal of International Medical Research · doi:10.1177/0300060519882570 · Cited by 31
“The telomere length decreases with increasing age in humans.(7) Telomere shortening is associated with inflammation, exposure to telomere inhibitory factors, and other types of damage.”
BackgroundSharma, R., & Padwad, Y. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101141 · Cited by 29
Anthracycline-induced cardiotoxicity and cell senescence: new therapeutic option?
Seara, F. D. A. C., Kasai-Brunswick, T. H., Nascimento, J. H. M., & de Carvalho, A. C. C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04605-7 · Cited by 30
The role of cellular senescence in cardiovascular disease
Xu, C., Qiu, Z., Guo, Q., Huang, Y., Zhao, Y., & Zhao, R. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02720-5 · Cited by 37
“Cellular senescence can interact with various pathological mechanisms in heart failure, such as mitochondrial dysfunction, autophagy disruption, and the activation of the neurohumoral system [145 – 147].”
Hu, J., Xu, J., Shen, S., Zhang, W., Chen, H., Sun, X., Qi, Y., Zhang, Y., Zhang, Q., Guo, M., et al. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10211-6 · Cited by 30
“It has been reported that senescence is closely associated with AAA formation, characterized by the upregulation of p16 and p21 protein expression [1, 20] .”
BackgroundATM-deficient neural precursors develop senescence phenotype with disturbances in autophagy
Sunderland, P., Augustyniak, J., Lenart, J., Bużańska, L., Carlessi, L., Delia, D., & Sikora, E. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111296 · Cited by 28
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging
Bartolo, A. D., Angelone, T., & Rocca, C. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107462 · Cited by 31
Mechanistic Insights of the LEMD2 p.L13R Mutation and Its Role in Cardiomyopathy
Chen, R., Buchmann, S., Kroth, A., Arias-Loza, P.-A., Kohlhaas, M., Wagner, N., Grüner, G., Nickel, A. G., Cirnu, A., Williams, T., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321929 · Cited by 30
Morin, D., Long, R., Panel, M., Laure, L., Taranu, A., Gueguen, C., Pons, S., Leoni, V., Caccia, C., Vatner, S. F., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.035 · Cited by 24
“SASP can lead to tissue dysfunction and has been involved in the development of cardiac hypertrophy [44,45] and it would be interesting to assess the potential role of SASP in the development of left ventricle hypertrophy by Hsp22 overexpression.”
BackgroundSuppression of autophagy induces senescence in the heart
Zhai, P., Sung, E., Shiheido‐Watanabe, Y., Takayama, K., Tian, Y., & Sadoshima, J. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.08.001 · Cited by 29
Salman, O., Zamani, P. L., Zhao, L., Dib, M., Gan, S., Azzo, J. D., Pourmussa, B., Richards, M., Javaheri, A., Mann, D. L., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033675 · Cited by 28
“18 Moreover, Zhu et al demonstrated that the combination of dasatinib, a tyrosine kinase inhibitor, and quercetin, an antioxidative agent, decreases the number of senescent cells and improves cardiac and vascular endothelial function in aged murine models.”
Anti-senescence therapies: a new concept to address cardiovascular disease
Stojanović, S. D., Thum, T., & Bauersachs, J. K. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf030 · Cited by 34
Dagher, O., Mury, P., Noly, P., Fortier, A., Lettre, G., Thorin, É., & Carrier, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.741542 · Cited by 30
Adili, A., Zhu, X., Cao, H., Tang, X., Wang, Y., Wang, J., Shi, J., Zhou, Q., & Wang, D. (2022) · Aging and Disease · doi:10.14336/ad.2021.0619 · Cited by 26
“Additionally, Passos et al found that length-independent telomere damage induces cardiomyocyte senescence, and that the clearance of senescent cells significantly attenuates age-related cardiac dysfunction [16].”
BackgroundInfluentialThe role of cardiomyocyte senescence in cardiovascular diseases: A molecular biology update
He, S., Li, Y., Yuan, C., Li, W., Tian, W., Chen, S., Li, N., Wu, M., & Jiang, J. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176961 · Cited by 25
SGLT2 inhibitors as a novel senotherapeutic approach
Yeşilyurt, Z. E., Qi, C., Wang, Y.-C., Simm, A., Deelen, L., Gasim, A. H. A., Lewis, F., & Ellison, G. M. (2025) · npj Aging · doi:10.1038/s41514-025-00227-y · Cited by 33
“It has been shown that removing senescent cells in aged mice, either pharmacologically using senolytics or genetically, improved myocardial dysfunction, led to the formation of new cardiomyocytes and decreased hypertrophy and fi brosis associated with cardiac aging 104 – 106 .”
The use of geroprotectors to prevent multimorbidity: Opportunities and challenges
Morsli, S., & Bellantuono, I. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111391 · Cited by 28
Senescence and Aging: Does It Impact Cancer Immunotherapies?
Maggiorani, D., & Beausejour, C. M. (2021) · Cells · doi:10.3390/cells10071568 · Cited by 25
Self-citationThe potential of Senolytics in transplantation
Matsunaga, T., Iske, J., Schroeter, A., Azuma, H., Zhou, H., & Tullius, S. G. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111582 · Cited by 22
Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Henson, S. M., & Aksentijević, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716517 · Cited by 25
“Evidence from both animal and human studies has shown that post-mitotic cardiomyocyte senescence is mediated by length-independent telomere damage (Ball and Levine, 2005; Anderson et al., 2019).”
A Unified Model of Age-Related Cardiovascular Disease
Fossel, M., Bean, J., Khera, N., & Kolonin, M. G. (2022) · Biology · doi:10.3390/biology11121768 · Cited by 26
“Cardiomyocytes [48,124] and cardiac fibroblasts [77] display the hallmarks of cell aging, including dysfunctional DNA repair, mitochondrial dysfunction, impaired contractility, and increased fibrosis, with the subsequent impairment of ejection fraction and heart failure [76,124–126].”
BackgroundNew Horizons in cellular senescence for clinicians
Witham, M. D., Granic, A., Miwa, S., Passos, J. F., Richardson, G. D., & Sayer, A. A. (2023) · Age and Ageing · doi:10.1093/ageing/afad127 · Cited by 26
“Navitoclax and other inhibitors of the BCL-2 family have been shown to be senolytic, reducing senescent cell burden in vivo in mice and improving haematopoietic stem cell and cardiac function during ageing [4, 88].”
BackgroundSelf-citationTelomere Checkpoint in Development and Aging
Kalmykova, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115979 · Cited by 29
“The accumulation of unrepairable damage in telomeres occurs in the tissues of aging primates and mice; noteworthily, the DDR signal is triggered at a normal average telomere length [78–80].”
BackgroundTrajectories in Cardiac Aging: Journey to the Crossroads of Inflammation and Metabolism
Dérumeaux, G., Sawaki, D., & Czibik, G. (2024) · Circulation · doi:10.1161/circulationaha.123.065116 · Cited by 23
Cellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
“…increased expression of p16 seems to play an important role in cardiac remodeling after myocardial infarction [91], the removal of senescent cells in normally aging INK-ATTAC mice [84, 92, 93], and to a lesser extent in a model of accelerated aging [66], leads to improvements in cardiac function.”
BackgroundDynamic Aging: Channeled Through Microenvironment
Tan, Q., Liang, N., Zhang, X., & Li, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.702276 · Cited by 28
“…as endothelin 3 (EDN3), transforming growth factor β 2 (TGFB2) and growth differentiation factor 15 (GDF15) to induce senescence in neighboring cells (Anderson et al., 2019; Li et al., 2020a). endothelial cells form the lining of blood vessels and serve as the interface between vessels and tissues…”
BackgroundAnthracycline-induced cardiotoxicity and senescence
Booth, L. K., Redgrave, R. E., Folaranmi, O., Gill, J. H., & Richardson, G. D. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.1058435 · Cited by 27
“Senescent cardiomyocytes have characteristics that promote myocardial remodeling as they are hypertrophic and express a profibrotic and pro-hypertrophic SASP (Anderson et al., 2019; Walaszczyk et al., 2019).”
BackgroundInfluentialSelf-citationTelomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
“Additionally, TIFs can be produced by ROS-induced guanine alteration, suggesting uncapping from shelterin disengagement, in addition to telomere shortening per se [197].”
Dungan, C. M., Wells, J. M., & Murach, K. A. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00553.2022 · Cited by 21
de Lange, P., Lombardi, A., Silvestri, E., Cioffi, F., Giacco, A., Iervolino, S., Petito, G., Senese, R., Lanni, A., & Moreno, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411676 · Cited by 26
“All of these compounds can be effectively administered orally, and their elimination half-life is less than 4 h, which implies complete clearance from the human body within 24 h [188].”
BackgroundThe link between obesity and aging - insights into cardiac energy metabolism
Owesny, P., & Grune, T. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111870 · Cited by 25
“21 studies confirmed the presence of senescent cells and a senescent-like phenotype in cardiomyocytes, suggesting their contribution to cardiac remodelling and dysfunction during aging (Anderson et al., 2019; Li et al., 2020).”
BackgroundAmitosenescence and Pseudomitosenescence: Putative New Players in the Aging Process
Wengerodt, D., Schmeer, C., Witte, O. W., & Kretz, A. (2019) · Cells · doi:10.3390/cells8121546 · Cited by 21
“Interestingly, in both senescent-like postmitotic cell entities classical SASP components, such as IL-1α and IL-1β, were not significantly involved [3,5].”
BackgroundCardiovascular inflammaging: Mechanisms, consequences, and therapeutic perspectives
Spray, L., Richardson, G. D., Haendeler, J., Altschmied, J., Rumampouw, V., Wallis, S. B., Georgiopoulos, G. A., White, S. J., Unsworth, A. J., Stellos, K., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102264 · Cited by 35
Self-citationCardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets
Zheng, P., Yan, W., Ding, Y.-N., Zhang, Y., Chen, Z., Qian, J., & Ge, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02630-7 · Cited by 39
“207,234 In addition, cardiovascular ageing may ultimately trigger heart failure by causing impaired cardiac function, fi brosis, and associated changes in genetic and biological processes.”
Capillaries as a Therapeutic Target for Heart Failure
Yoshida, Y., Shimizu, I., & Minamino, T. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17064 · Cited by 22
TElomeric repeat-containing RNA (TERRA): Physiological functions and relevance in cancer
Kroupa, M., Tomášová, K., Kavec, M., Škrobánek, P., Büchler, T., Kumar, R., Vodičková, Ľ., & Vodička, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.913314 · Cited by 20
“Additionally, the accumulation of DNA damage at the ends of chromosomes was observed in non-dividing differentiated somatic cells (14) presumably due to the action of DNA damaging agents (15).”
BackgroundNew Trends in Aging Drug Discovery
Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Ortega‐Gutiérrez, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082006 · Cited by 22
“Pharmacological decrease in cardiac senescent cell burden upon senolytics (D + Q or navitoclax) treatment resulted in a similar beneficial effect, partly reversing cardiac dysfunction of animal models [98,99,104].”
BackgroundCellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges
Li, D., Li, Y., Ding, H., Wang, Y., Xie, Y., & Zhang, X. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100439 · Cited by 22
“This intervention led to a decrease in cardiomyocyte size and fibrosis, with cardiac function and left ventricular mass remaining relatively stable [26].”
BackgroundInfluentialApplication of STED imaging for chromatin studies
Kostiuk, G., Bucevičius, J., Gerasimaitė, R., & Lukinavičius, G. (2019) · Journal of Physics D Applied Physics · doi:10.1088/1361-6463/ab4410 · Cited by 19
Long-lived post-mitotic cell aging: is a telomere clock at play?
Burbano, M. S. J., & Gilson, É. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111256 · Cited by 22
Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions
Proshkina, E., Solovev, I. A., Shaposhnikov, M. V., & Moskalev, A. (2020) · Molecular Biology · doi:10.1134/s0026893320060096 · Cited by 21
A Mitochondrial Basis for Heart Failure Progression
Watson, W. D., Arvidsson, P. M., Miller, J. J. J. J., Lewis, A. J., & Rider, O. J. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07582-0 · Cited by 24
Self-citationDeng, Y., Gao, H., & Wu, Q. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c07268 · Cited by 20
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Aging at the Crossroads of Organ Interactions: Implications for the Heart
Sen, I., Trzaskalski, N. A., Hsiao, Y., Liu, P. P., Shimizu, I., & Dérumeaux, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325637 · Cited by 23
“42 Such senescent-like cardiomyocytes produce a profibrotic and prohypertrophic SASP phenotype with the increased expression of GDF15 (growth differentiation factor 15), TGF-β 2, and EDN3 (endothelin 3).”
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 20
Selective Cardiomyocyte Oxidative Stress Leads to Bystander Senescence of Cardiac Stromal Cells
Martini, H., Lefèvre, L., Sayir, S., Itier, R., Maggiorani, D., Dutaur, M., Marsal, D. J., Roncalli, J. G., Pizzinat, N., Cussac, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052245 · Cited by 21
“SASP related factors such as pro-inflammatory cytokines play a deleterious role in cardiovascular diseases, in particular in the context of aging or in response to anthracycline treatment [11,14,15].”
BackgroundSelf-citationThe Intra- and Extra-Telomeric Role of TRF2 in the DNA Damage Response
Imran, S. A. M., Yazid, M. D., Cui, W., & Lokanathan, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189900 · Cited by 19
Cellular Senescence and Aging in Myotonic Dystrophy
Hasuike, Y., Mochizuki, H., & Nakamori, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042339 · Cited by 22
“In particular, telomere length-independent DNA damage due to aging-related mitochondrial dysfunction and increased oxidative stress is reported to induce cardiomyocytes senescence, leading to heart failure [60].”
BackgroundBooth, L. K., Redgrave, R. E., Tual‐Chalot, S., Spyridopoulos, I., Phillips, H. M., & Richardson, G. D. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_4 · Cited by 21
Self-citationSenescence: a double-edged sword in beta-cell health and failure?
Varghese, S. S., & Dhawan, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196460 · Cited by 23
“Activation of many facets of senescence has been reported in a variety of postmitotic cells including beta-cells (6, 9–11, 33–36), suggesting that senescence in such cells begins as a stress-response (36, 37), temporally separated from permanent replicative arrest.”
BackgroundSavić, R., Yang, J., Koplev, S., An, M. C., Patel, P. L., O’Brien, R., Dubose, B. N., Dodatko, T., Rogatsky, E., Sukhavasi, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113371 · Cited by 23
“6–10 Given the potential for senotherapy to improve age-associated cardiovascular pathologies, there is a critical need to understand and identify markers of senescent cells in human disease settings.”
BackgroundHabieb, M. E., Mohamed, M. A. E. H., Gamal, D. M. E., Hawas, A. M., & Mohamed, T. M. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104288 · Cited by 25
Rosa, M. D., Barnes, R. P., Detwiler, A. C., Nyalapatla, P. R., Wipf, P., & Opresko, P. L. (2025) · Nature Communications · doi:10.1038/s41467-024-55638-4 · Cited by 34
Molnár, A., Pásztor, D. T., & Merkely, B. P. (2022) · Cells · doi:10.3390/cells11213389 · Cited by 18
Mahoney, S. A., Dey, A. K., Basisty, N., & Herman, A. B. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00352.2023 · Cited by 21
Cellular Senescence in Arterial Diseases
Shimizu, I., & Minamino, T. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.1.79 · Cited by 21
Sharma, R. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3970 · Cited by 20
“Inter-estingly, development of cellular senescence has also been noted in mitotically inactive and terminally differentiated cells such as neurons 34 and cardiomyocytes 35 which indicates that loss of replicative potency alone may not be an essential requirement for cellular senescence.”
The senotherapeutic potential of phytochemicals for age-related intestinal disease
Costa, C. M., Pedrosa, S. S., Kirkland, J. L., Reis, F., & Madureira, A. R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102619 · Cited by 19
Self-citationSenolytic therapies for cardiovascular aging: tackling fibrosis and metabolic dysfunction
Atlante, S., Zamperla, M. G., Cis, L., Farsetti, A., & Gaetano, C. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.009 · Cited by 25
Cellular Senescence, Inflammaging and Cardiovascular Disease
Zanders, L., Arifaj, D., Wagner, J. U. G., & Dimmeler, S. (2026) · Immunological Reviews · doi:10.1111/imr.70084 · Cited by 33
Ключевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции
Proshkina, E., Соловьёв, И. А., Shaposhnikov, M. V., & Moskalev, A. A. (2020) · Molecular Biology · doi:10.31857/s0026898420060099 · Cited by 21
Targeting G-Quadruplex DNA for Cancer Chemotherapy
Acharya, P. C., & Debbarma, S. (2022) · Current Drug Discovery Technologies · doi:10.2174/1570163819666220214115408 · Cited by 19
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Molecular Basis of Cardiac and Vascular Injuries Associated With COVID-19
Hachim, M. Y., Heialy, S. A., Senok, A. C., Hamid, Q. A., & Alsheikh-Ali, A. A. A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.582399 · Cited by 19
“NDUFA4L2 plays a role in protecting cardiomyocytes from apoptosis and mitochondrial dysfunction during ischemia/reperfusion event, while NDUFB7 has been linked with mitochondrial dysfunction and cardiomyocyte senescence (57, 58).”
BackgroundAdiponectin inhibits D‑gal‑induced cardiomyocyte senescence via AdipoR1/APPL1
Liu, R., Meng, J., & Lou, D. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12358 · Cited by 18
“cardiomyocyte senescence, as a part of the aging process, is directly associated with the dysfunc‐ tion of myocardial tissues (22), the deterioration of which is often induced by oxidative stress (23).”
BackgroundTargeting senescent cells in atherosclerosis: Pathways to novel therapies
Tian, Y., Shao, S., Feng, H., Zeng, R., Li, S., & Zhang, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102502 · Cited by 16
SUMOylation of TP53INP1 is involved in miR-30a-5p-regulated heart senescence
Hong, Y., Wu, C., Li, J.-Z., Song, F., Hu, Y., Han, Y., Mao, Y.-J., Wu, W., Wang, Y., & Li, G. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01347-3 · Cited by 17
The effect of TMAO on aging-associated cardiovascular and metabolic pathways and emerging therapies
Alsulami, M., Alamri, H. S., Barhoumi, T., Munawar, N., & Alghanem, B. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05356-2 · Cited by 19
“Cardiomyocyte senescence may enhance metabolic dysfunction and inflammation [32, 33].”
InfluentialSIRT3-Mediated Mitochondrial Regulation and Driver Tissues in Systemic Aging
Šešelja, K., Šimunić, E., Sobočanec, S., Podgorski, I. I., Pinterić, M., Hadžija, M. P., Balog, T., & Belužić, R. (2025) · Genes · doi:10.3390/genes16121497 · Cited by 19
“Other organs, such as skeletal muscle, brain, and heart, also accumulate damaged or senescent cells, yet their contribution to systemic decline is more likely cell-autonomous or local rather than via broad endocrine-like secretory loops [29,30].”
Ko, J., Jang, Y. C., Quindry, J. C., Guttmann, R. P., Cosío-Lima, L., Powers, S. K., & Lee, Y. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003058 · Cited by 19
“Importantly, because cardiac senescence contributes to cardiac fibrosis and impairment (10), and EXE defers or remits cardiac aging, it seems reasonable to presume that EXE-mediated antisenescence in the heart against metabolic disorder may be a novel protective mechanism.”
BackgroundParishin treatment alleviates cardiac aging in naturally aged mice
Zhou, S., Zhao, X., Wu, L., Ren, Y., Sun, L., Zhang, Q., Gong, C., Liu, Y., Xiang, L., Li, S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22970 · Cited by 15
Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy
Souidi, M., Resta, J., Dridi, H., Sleiman, Y., Reiken, S. R., Formoso, K., Colombani, S., Amédro, P., Meyer, P., Charrabi, A., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13411 · Cited by 17
Self-citationBartolo, A. D., Pasqua, T., Romeo, N., Rago, V., Perrotta, I. D., Giordano, F., Granieri, M. C., Marrone, A., Mazza, R., Cerra, M. C., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05192-w · Cited by 17
“Compelling evidence indicates a higher incidence and morbidity of HF with advanced age, since aged cardiomyocytes gain a senescent phenotype characterized by cellular hypertrophy, interstitial fibrosis and oxidative stress [63, 64].”
BackgroundIdentification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart
Maggiorani, D., Santin, Y., Formoso, K., Drapé, E., Martini, H., Brun, S., Cousin, G., Lairez, O., Lezoualc’h, F., Parini, A., et al. (2024) · Aging Cell · doi:10.1111/acel.14204 · Cited by 15
“…the upregulation of Prom2 at the mRNA and protein level was part of the Doxo-induced senescence program, characterized by an increase in p21 and p15 gene expression, together with the previously identified cardiomyocyte SASP factors GDF15 and TGF β 2 (Anderson et al., 2019) (Figure 4d–f).”
BackgroundMethodInfluentialSelf-citationHeart of the matter: Mitochondrial dynamics and genome alterations in cardiac aging
Gabillard-Lefort, C., Thibault, T., Lenaers, G., Wiesner, R. J., Mialet‐Perez, J., & Baris, O. R. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112044 · Cited by 17
“In the murine heart, a recent study identified an age-dependent accumulation of persistent telomeric damage that act as a key driver of cardiomyocyte senescence (Anderson et al., 2019).”
Self-citationParkin: A targetable linchpin in human malignancies
Perwez, A., Wahabi, K., & Rizvi, M. M. A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188533 · Cited by 18
Recent Advances in Senolysis for Age-Related Diseases
Aratani, S., & Nakanishi, M. (2023) · Physiology · doi:10.1152/physiol.00003.2023 · Cited by 19
Kosmopoulos, M., Chiriacò, M., Stamatelopoulos, K. S., Tsioufis, C. P., Masci, P. G., Kontogiannis, C., Mengozzi, A., Pugliese, N. R., Taddei, S., Virdis, A., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111604 · Cited by 18
Zhao, S., Zhang, Y., Zhao, Y. R., & Lu, X. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.02.002 · Cited by 15
Sanz‐Ros, J., Huete-Acevedo, J., Mas‐Bargues, C., Romero-García, N., Dromant, M., van Weeghel, M., Janssens, G. E., & Borrás, C. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04255-z · Cited by 14
“Interest-ingly, cellular senescence has traditionally been viewed as a property of proliferating cells; however, the heart, as a tissue whose primary cells are post-mitotic, also shows characteristics of cellular senescence, a trait termed ami-tosenescence [42].”
Links between telomere dysfunction and hallmarks of aging
Li, S., Liu, Z., Zhang, J., & Li, L. (2023) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2023.503617 · Cited by 16
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?
Tini, G., Cannata, A. N., Canepa, M., Masci, P. G., Pardini, M., Giacca, M., Sinagra, G., Marchionni, N., del Monte, F., Udelson, J. E., et al. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10114-9 · Cited by 13
Signs of Similarities and Differences in Cellular Models of Aging: A Scoping Review
Васильевна, М. Г., & Khokhlov, A. N. (2022) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392522030087 · Cited by 16
“In particular, there is reason to assume that postmitotic cells also acquire the senescence-associated secretory phenotype [41, 42].”
BackgroundSenescence Biomarkers CKAP4 and PTX3 Stratify Severe Kidney Disease Patients
McCallion, S., McLarnon, T., Cooper, E., English, A. R., Watterson, S., Chemaly, M., McGeough, C. M., Eakin, A., Ahmed, T., Gardiner, P. V., et al. (2024) · Cells · doi:10.3390/cells13191613 · Cited by 13
“Cellular senescence can also occur in terminally differentiated cells such as cardiomyocytes, neurons, and nephrons, characterised by the accumulation of senescent cells, which is hallmark of ageing and ageing pathologies [21,22].”
BackgroundCellular senescence and cell therapy in cardiovascular diseases
Chang, D., Wang, J., Zhu, S., Shentu, Y., Wang, Y., Zhu, P., & Ōno, M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04731-6 · Cited by 15
“P53 promotes mitochondrial dysfunction and inhibits Parkin-mediated mitoph-agy in senescent cardiomyocytes, accumulating reactive oxygen species (ROS) and telomere damage, standard features of DNA damage in rarely-dividing post-mitotic cells [30–32].”
Silva, E. D., Tomé, I., Vasques‐Nóvoa, F., Conceição, G., da Silva, A. M., Barros, A. S., Mendes‐Ferreira, P., Santos-Ribeiro, D., Gonçalves, A., Angélico‐Gonçalves, A., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf208 · Cited by 19
“While previous studies 20,22,60 have found that increased myocardial senescence is linked to cardiac dysfunction in chronologically aged mice and clearance of SCs using senolytics reduced myocardial fibrosis, LV hypertrophy, and decreased myocardial cytokine expression, those studies did not use an…”
Self-citationTelomere dysfunction in chronic liver disease: The link from aging
Penrice, D. D., Jalan‐Sakrikar, N., Jurk, D., Passos, J. F., & Simonetto, D. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000426 · Cited by 17
“[35] 39] Studies have also shown that in stress conditions, telomeres are favored sites for DNA damage, and this damage can also be independent of telomere length and telomerase activity in non-proliferative cells.”
Self-citationMonaghan, P. (2024) · Biogerontology · doi:10.1007/s10522-023-10081-8 · Cited by 24
“Length independent telomere damage can occur in non-mitotic tissues such as cardiomyocytes (Anderson et al. 2019).”
BackgroundDabour, M. S., Abdelgawad, I. Y., Sadaf, B., DANIEL, M. R., Grant, M. K. O., Seelig, D. M., & Zordoky, B. N. M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117288 · Cited by 17
“The p38 MAPK compromises four isoforms: p38 α , p38 β , p38 γ , and p38 δ , with p38 α and p38 β isoforms being the two predominant isoforms of p38 MAPK in the heart [29].”
BackgroundWang, T., Shi, X., Xu, X., Zhang, J., Ma, Z., Meng, C., Jiao, D., Wang, Y., Chen, Y., He, Z., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123129 · Cited by 18
Weight of time: exploring the link between obesity and aging
Ragusa, F. S., Tanaka, T., Veronese, N., Mansueto, P., Dominguez, L. J., Barbagallo, M., & Ferrucci, L. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03106-4 · Cited by 16
“Notably, this process occurs regardless of telomere length or cell division, helping to explain how senescence accumulates in cardiomyocytes, even though they are largely non-dividing cells [ 43].”
Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models
Inci, N., Kamali, D., Akyildiz, E. O., Tahir Turanli, E., & Bozaykut, P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.828058 · Cited by 13
Myofibroblast senescence promotes arrhythmogenic remodeling in the aged infarcted rabbit heart
Baggett, B., Murphy, K. R., Sengun, E., Mi, E., Cao, Y., Turan, N. N., Lu, Y., Schofield, L., Kim, T. Y., Kabakov, A. Y., et al. (2023) · eLife · doi:10.7554/elife.84088 · Cited by 12
“…drug navitoclax limits cardiac fibrosis in infarcted and non-infarcted mice and improves the survival and cardiac function of infarcted young and aged mice, but little is known about the effects of senescence on arrhythmogenesis with age ( Walaszczyk et al., 2019 ; Anderson et al., 2019 ).”
BackgroundInfluentialHyperactive mTORC1/4EBP1 signaling dysregulates proteostasis and accelerates cardiac aging
Zarzycka, W., Kobak, K. A., King, C. J., Peelor, F. F., Miller, B. F., & Chiao, Y. A. (2024) · GeroScience · doi:10.1007/s11357-024-01368-w · Cited by 14
“Cellular senescence of cardiac cells has been shown as a contributing mechanism of age-related cardiac dysfunction [45, 46].”
Aging and HFpEF: Are we running out of time?
Withaar, C., Li, S., Meems, L. M. G., Silljé, H. H. W., & de Boer, R. A. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.04.006 · Cited by 16
Deryabin, P. I., Ivanova, J. S., & Borodkina, A. V. (2022) · Molecular Human Reproduction · doi:10.1093/molehr/gaac039 · Cited by 13
Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?
Wei, Z., Chai, H., Chen, Y., Cheng, Y., & Liu, X. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.08.006 · Cited by 14
Methamphetamine induces cardiomyopathy through GATA4/NF-κB/SASP axis-mediated cellular senescence
Zhao, X., Lu, J., Zhang, C., Chen, C., Zhang, M., Zhang, J., Du, Q., & Wang, H. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116457 · Cited by 12
Metadata
- Authors
- Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., Proctor, C., Correia‐Melo, C., Victorelli, S., Fielder, E., Berlinguer‐Palmini, R., Owens, A., Greaves, L. C., Kolsky, K. L., Parini, A., Douin‐Echinard, V., LeBrasseur, N. K., Arthur, H. M., Tual‐Chalot, S., Schafer, M. J., Roos, C. M., Miller, J. D., Robertson, N., Mann, J., Adams, P. D., Tchkonia, T., Kirkland, J. L., Mialet‐Perez, J., Richardson, G. D., & Passos, J. F.
- Affiliations
- Newcastle University (GB)
- Inserm (FR)
- Mayo Clinic (US)
- Wellcome Centre for Mitochondrial Research (GB)
- Cancer Research UK Scotland Institute (GB)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- ORCID
- Lagnado, Anthony
- Maggiorani, Damien
- Walaszczyk, Anna
- Dookun, Emily
- Chapman, James
- Birch, Jodie
- Salmonowicz, Hanna
- Ogrodnik, Mikolaj
- Jurk, Diana
- Proctor, Carole
- Correia‐Melo, Clara
- Victorelli, Stella
- Fielder, Edward
- Berlinguer‐Palmini, Rolando
- Greaves, Laura C
- Parini, Angelo
- Douin‐Echinard, Victorine
- LeBrasseur, Nathan K
- Arthur, Helen M
- Tual‐Chalot, Simon
- Schafer, Marissa J
- Miller, Jordan D
- Robertson, Neil
- Mann, Jelena
- Adams, Peter D
- Kirkland, James L
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- Venue
- The EMBO Journal
- Published
- 2019-02-08
- Volume
- 38
- Issue
- 5
- Pages
- e100492
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC6396144
- OpenAlex
- W2913284769
- Semantic Scholar
- f2b575f4b8dabea90337c591a95d86658c57701d
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 59 · 2025: 80 · 2024: 83 · 2023: 68 · 2022: 77 · 2021: 70 · 2020: 67 · 2019: 28
- FWCI
- 41.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Connor Group
- Noaber Foundation
- Région Occitanie, France
- Medical Research Council and Arthritis UK funded centre for integrated Musculoskeletal Ageing (MR/K0063121/1)
- RCUK | Biotechnology and Biological Sciences Research Council (BB/H022384/1, BB/K017314/1)
- British Heart Foundation (PG/15/85/31744)
- Foundation for the National Institutes of Health (AG013925)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- cardiomyocyte senescence, cellular senescence, cardiac aging, senolytics, senescence-associated secretory phenotype, p21, p16INK4a, mitochondrial dysfunction, myocardial fibrosis, cardiac hypertrophy, age-related cardiac dysfunction
- MeSH terms
- Aging, Animals, DNA Damage, Female, Fibrosis, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitosis, Monoamine Oxidase, Phenotype, RNA, Cellular Senescence, Rats, Sprague-Dawley, Mice, Knockout, Telomerase, Myocytes, Cardiac, Mice, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.